​​​​​ ​

Photobiomodulation Equipment and Training - THOR Photomedicine

Select Region

Information contained on this page may not be appropriate for your region, please select your region from below. To navigate back to this region selector, please click "Region" in the footer.
United States
Menu
Do More With A THOR
Lots of happy THOR customer testimonials
NovoTHOR Whole Body Light Pod

THOR Photobiomodulation Therapy for Wound Healing

Introduction

Treatment Video

Clinical Research

Physiological Changes

How it works

Training Dates

Testimonies

Information Pack

Treatment Video

THOR Photobiomodulation Wound healing

This Diabetic patient had a non healing wound. PBM was used to heal it.

View more videos


Clinical Research

[top]


OUR CUSTOMERS INCLUDE:
Our customers include: Harvard Medical School, Massachusetts General Hospital, British Army, RAF, Royal Navy, Team GB, Manchester United, MIT, Harvard School of Public Health, Cedars Sinai, City of Hope, USUHS
THOR Customers
Testimonials Customer Service Clinical Applications Equipment Service and Repairs Introduction to Photobiomodulation TOS, Privacy Policy, and Cookies Photobiomodulation eNews Medical practitioners advice
Directions Cold Laser Photobiomodulation Lancet Neck Pain
Follow us:   THOR on Facebook THOR on Twitter THOR on LinkedIn THOR on Instagram THOR on YouTube
THOR Laser logo

Copyright © 2024 THOR Photomedicine Ltd
All Rights Reserved
Technical inquiries to THOR

THOR Photomedicine Ltd is an ISO 13485:2016 certified medical device company.

The THOR LX2.3 Photobiomodulation system has a medical CE mark (EC certificate). It is indicated for oral mucositis, tendinopathies, joint pain, neck pain and back pain for marketing in the UK, EU and Australia.

The THOR LX2.3 Photobiomodulation system is also FDA Cleared for marketing in the United States for: Temporary increase in local blood circulation, temporary relief of minor muscle and joint aches, pains and stiffness and relaxation of muscles; for muscle spasms, and minor pain and stiffness associated with arthritis.

Excluding the THOR LED Helmet, THOR LX2 and NovoTHOR systems are manufactured under conditions fulfilling the quality system requirements of Annex II, excluding (4), of the directive 93/42/EEC as amended and satisfy the applicable international harmonised standards.

Positive systematic reviews published by:

The British Medical Journal (BMJ), The Lancet, the International Association for the Study of Pain (IASP), the World Health Organisation (WHO), the Multinational Association for Supportive Care in Cancer (MASCC), the European Society for Medical Oncology (ESMO)

Appropriate regulatory clearance or approvals include:

Quality certificates

​​​​​